Literature DB >> 23408166

Lithium: a versatile tool for understanding renal physiology.

Bellamkonda K Kishore1, Carolyn M Ecelbarger.   

Abstract

By virtue of its unique interactions with kidney cells, lithium became an important research tool in renal physiology and pathophysiology. Investigators have uncovered the intricate relationships of lithium with the vasopressin and aldosterone systems, and the membrane channels or transporters regulated by them. While doing so, their work has also led to 1) questioning the role of adenylyl cyclase activity and prostaglandins in lithium-induced suppression of aquaporin-2 gene transcription; 2) unraveling the role of purinergic signaling in lithium-induced polyuria; and 3) highlighting the importance of the epithelial sodium channel (ENaC) in lithium-induced nephrogenic diabetes insipidus (NDI). Lithium-induced remodeling of the collecting duct has the potential to shed new light on collecting duct remodeling in disease conditions, such as diabetes insipidus. The finding that lithium inhibits glycogen synthase kinase-3β (GSK3β) has opened an avenue for studies on the role of GSK3β in urinary concentration, and GSK isoforms in renal development. Finally, proteomic and metabolomic profiling of the kidney and urine in rats treated with lithium is providing insights into how the kidney adapts its metabolism in conditions such as acquired NDI and the multifactorial nature of lithium-induced NDI. This review provides state-of-the-art knowledge of lithium as a versatile tool for understanding the molecular physiology of the kidney, and a comprehensive view of how this tool is challenging some of our long-standing concepts in renal physiology, often with paradigm shifts, and presenting paradoxical situations in renal pathophysiology. In addition, this review points to future directions in research where lithium can lead the renal community.

Entities:  

Keywords:  aldosterone; arginine vasopressin; diabetes insipidus; glycogen synthase kinase-3; prostaglandins; purinergic signaling

Mesh:

Substances:

Year:  2013        PMID: 23408166      PMCID: PMC3651632          DOI: 10.1152/ajprenal.00718.2012

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  130 in total

1.  Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus.

Authors:  H M Allen; R L Jackson; M D Winchester; L V Deck; M Allon
Journal:  Arch Intern Med       Date:  1989-05

2.  Lithium-induced NDI in rats is associated with loss of alpha-ENaC regulation by aldosterone in CCD.

Authors:  Jakob Nielsen; Tae-Hwan Kwon; Jørgen Frøkiaer; Mark A Knepper; Søren Nielsen
Journal:  Am J Physiol Renal Physiol       Date:  2005-12-06

3.  Genetic deletion of the P2Y2 receptor offers significant resistance to development of lithium-induced polyuria accompanied by alterations in PGE2 signaling.

Authors:  Yue Zhang; Ioana L Pop; Noel G Carlson; Bellamkonda K Kishore
Journal:  Am J Physiol Renal Physiol       Date:  2011-10-05

4.  Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria.

Authors:  Reena Rao; Ming-Zhi Zhang; Min Zhao; Hui Cai; Raymond C Harris; Matthew D Breyer; Chuan-Ming Hao
Journal:  Am J Physiol Renal Physiol       Date:  2004-12-07

Review 5.  Lithium: occurrence, dietary intakes, nutritional essentiality.

Authors:  Gerhard N Schrauzer
Journal:  J Am Coll Nutr       Date:  2002-02       Impact factor: 3.169

Review 6.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12

7.  GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity.

Authors:  Reena Rao; Satish Patel; Chuanming Hao; James Woodgett; Raymond Harris
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

8.  Amiloride restores renal medullary osmolytes in lithium-induced nephrogenic diabetes insipidus.

Authors:  Jennifer J Bedford; John P Leader; Rena Jing; Logan J Walker; Janet D Klein; Jeff M Sands; Robert J Walker
Journal:  Am J Physiol Renal Physiol       Date:  2008-01-23

9.  Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla.

Authors:  D Marples; S Christensen; E I Christensen; P D Ottosen; S Nielsen
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  Lithium induces autophagy by inhibiting inositol monophosphatase.

Authors:  Sovan Sarkar; R Andres Floto; Zdenek Berger; Sara Imarisio; Axelle Cordenier; Matthieu Pasco; Lynnette J Cook; David C Rubinsztein
Journal:  J Cell Biol       Date:  2005-09-26       Impact factor: 10.539

View more
  27 in total

Review 1.  Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.

Authors:  B K Kishore; N G Carlson; C M Ecelbarger; D E Kohan; C E Müller; R D Nelson; J Peti-Peterdi; Y Zhang
Journal:  Acta Physiol (Oxf)       Date:  2015-05-04       Impact factor: 6.311

2.  Role of adenylyl cyclase 6 in the development of lithium-induced nephrogenic diabetes insipidus.

Authors:  Søren Brandt Poulsen; Tina Bøgelund Kristensen; Heddwen L Brooks; Donald E Kohan; Timo Rieg; Robert A Fenton
Journal:  JCI Insight       Date:  2017-04-06

Review 3.  Molecular mechanisms in lithium-associated renal disease: a systematic review.

Authors:  Soham Rej; Shamira Pira; Victoria Marshe; André Do; Dominique Elie; Karl J Looper; Nathan Herrmann; Daniel J Müller
Journal:  Int Urol Nephrol       Date:  2016-06-29       Impact factor: 2.370

Review 4.  Collecting duct intercalated cell function and regulation.

Authors:  Ankita Roy; Mohammad M Al-bataineh; Núria M Pastor-Soler
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-28       Impact factor: 8.237

5.  Regulation of mineral metabolism by lithium.

Authors:  Hajar Fakhri; Ganesh Pathare; Abul Fajol; Bingbing Zhang; Thomas Bock; Reinhard Kandolf; Erwin Schleicher; Jürg Biber; Michael Föller; Undine E Lang; Florian Lang
Journal:  Pflugers Arch       Date:  2013-09-07       Impact factor: 3.657

6.  Lithium in kidney diseases: big roles for the smallest metal.

Authors:  Man J Livingston; Zheng Dong
Journal:  J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 10.121

Review 7.  Involvement of ENaC in the development of salt-sensitive hypertension.

Authors:  Tengis S Pavlov; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2016-12-21

8.  P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.

Authors:  Yue Zhang; Janos Peti-Peterdi; Christa E Müller; Noel G Carlson; Younis Baqi; David L Strasburg; Kristina M Heiney; Karie Villanueva; Donald E Kohan; Bellamkonda K Kishore
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

9.  Drowning in data: early responses of renal cortical collecting duct cells to lithium.

Authors:  John Leader; Jennifer Bedford; Robert J Walker
Journal:  Ann Transl Med       Date:  2019-12

10.  Clopidogrel attenuates lithium-induced alterations in renal water and sodium channels/transporters in mice.

Authors:  Yue Zhang; János Peti-Peterdi; Kristina M Heiney; Anne Riquier-Brison; Noel G Carlson; Christa E Müller; Carolyn M Ecelbarger; Bellamkonda K Kishore
Journal:  Purinergic Signal       Date:  2015-09-19       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.